α-melanocyte-stimulating hormone and acute renal failure

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 4, 1998, Pages 413-417

  Kohda, Yukimasa ^a   Chiao, Hsi ^a   Star, Robert A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA INTERMEDIN; CORTICOTROPIN; GAMMA INTERMEDIN; INTERMEDIN; MELANOCORTIN RECEPTOR; NITRIC OXIDE; PROSTAGLANDIN INHIBITOR;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL TISSUE; DRUG MECHANISM; HORMONAL REGULATION; INFLAMMATION; INHIBITION KINETICS; KIDNEY TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ALPHA-MSH; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; ISCHEMIA; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES;

EID: 0031875963     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199807000-00011     Document Type: Review

References (32)

1. Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RW, Najarian JS, Matas AJ. Delayed graft function, acute rejection, and outcome after cadaver renal transplanation. The multivariate analysis. Transplantation 1995; 59:962-968.
2. Rabb H, O'Meara YM, Madema P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int 1997; 51:1463-1468.
3. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci 1994; 91:1691-1695.
4. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA. α-Melanocyte-•• stimulating hormone projects against renal injury after ischemia in mice and rats. J Clin Invest 1997; 99:1165-1172. This paper presents the first evidence that α-MSH inhibits renal injury from ischemia/reperfusion, even when first started 6 h into the reperfusion period. α-MSH inhibited maladaptive inflammatory and NO cascades initiated during the reperfusion period.
5. Chiao H, Foster S, Thomas R, Lipton J, Star RA. α-Melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1996; 97:2038-2044.
6. Rajora N, Boccoli G, Burns D, Sharma S, Catania AP, Lipton JM. α-MSH • modulates local and circulating tumor necrosis factor-α in experimental brain inflammation. J Neurosci 1997; 17:2181-2186. This paper found that α-MSH acts directly on brain cells to inhibit production of tumor necrosis factor-α. α-MSH could be given either centrally or systemically. Brain expressed the melanocortin-1 α-MSH receptor.
7. Chiao H, Nakashima O, Chavez R, Foster S, Lipton JL, Star RA. α-inhibits hepatic and renal inflammation [abstract]. J Am Soc Nephrol 1995; 6:832.
8. Grabbe S, Bhardwaj RS, Mahnke K, Simon MM, Schwarz T, Luger TA. α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 1996; 156:473-478.
9. Rajora N, Boccoli G, Catania A, Lipton JM. α-MSH modulates experimental inflammatory bowel disease. Peptides 1997; 18:381-385.
10. Huh SK, Lipton JM, Batjer HH. The protective effects of α-melanocyte • stimulating hormone on canine brain stem ischemia. Neurosurgery 1997; 40:132-139. α-MSH hastened recovery of brainstem auditory evoked potentials in dogs subjected to reversible brain ischemia. The mechanism of action was not studied.
11. Van DM, Hamers FP, Lankhorst AJ, Joosten EA, Gispen WH. Beneficial • effects of the melanocortin alpha-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury. Neurosurgery 1997; 40:122-130. α-MSH improved recovery of motion, stature, and motor evoked potentials in rats subjected to a moderately severe weight drop injury. α-MSH was as effective as steroids. The authors proposed that α-MSH could be a new treatment of traumatic spinal cord injury.
12. Guarini S, Bazzani C, Bertolini A. Resuscitating effect of melanocortin • peptides affer prolonged respiratory arrest. Br J Pharmacol 1997; 121:1454-1460. α-MSH allowed survival after lethal hypoxic respiratory arrest. It increased blood pressure, pulse, and cardiac output, and this effect was not mediated by catecholamines.
13. Lipton JM, Ceriani G, Macaluso A, McCoy D, Carnes K, Biltz J, Catania A. Antiinflammatory effects of the neuropeptide α-MSH in acute, chronic, and systemic inflammation. Ann NY Acad Sci 1994; 741:137-148.
14. Catania A, Lipton JM. α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev 1993; 14:564-576.
15. Star RA, Rajora N, Huang J, Chavez R, Catania A, Lipton JM. Evidence of autocrine modulation of macrophage nitric oxide synthese by α-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 1995; 92:8016-8020.
16. Rajora N, Ceriani G, Catania A, Star RA, Murphy MT, Lipton JM. α-MSH production, receptors, and influence on neopterin. in a human monocyte/macrophage cell line. J Leukoc Biol 1996; 59:248-253.
17. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JL. The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vivo. Peptides 1996; 17:675-669.
18. Weidenfeld J, Crumeyrolle-Arias M, Haour F. Effect of bacterial endotoxin and interleukin-1 on prostaglandin biosynthesis by the hippocampus of mouse brain: role of interleukin-1 receptors and glucocorticoids. Neuroendocrinology 1995; 62:39-46.
19. Lipton JM, Catania A. Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol Today 1997; 18:140-145.
20. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, Luger TA. Proopiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol 1996; 156:517-2521.
21. Kohda Y, Craig L, Chiao H, Star R. Distribution of renal melanocortin-1 • α-MSH receptors [abstract]. J Am Soc Nephrol 1997; 8:590A. This is an immunohistochemistry study using rabbit polyclonal antibodies to melanocortin-1 and melanocortin-5. Melanocortin-1 receptors were expressed on neutrophils and apical membranes of collecting ducts. Melanocortin-1 was also detected by protein blotting on mouse cortical tubule cells. Neutrophils also express melanocortin-5.
22. Huang J, Chavez R, Miller RT, Lipton J, Star RA. α-MSH inhibits induction on nitric oxide synthase. chemokine MCP-1, and protein kinase C in macrophages [abstract]. J Am Soc Neph 1995; 6:832.
23. Nathan C. Inducible nitric oxide synthese: what difference does it make? J Clin Invest 1997; 100:2417-2423.
24. Catania A, Manfredi MG, Airaghi L, Ceriani G, Gandino A, Lipton JM. Cytokine antagonists in infectious and inflammatory disorders. Ann NY Acad Sci 1994; 741:149-161.
25. Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM. The neuropeptide α-MSH inhibits experimental arthritis in rats. Neuroimmunomodulation 1994; 1:28-32.
26. Airaghi L, Lettino M, Manfredi GM, Lipton JM, Catania A. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am Heart J 1995; 130:204-211.
27. Adan RA, Gispen WH. Brain melanocortin receptors: from cloning to • function. Peptides 1997; 18:1279-1287. This is an up-to-date review of the molecular biology, pharmacology, and signaling of the melanocortin receptors.
28. Bhardwaj R, Becher E, Mahnke K, Hartmeyer M, Schwarz T, Scholzen T, • Luger TA. Evidence for the differential expression of the function a-melanocyle-stimulating hormone receptor MC-1 human monocytes. J Immonol 1997; 158: 3378-3384. Human monocytes express mRNA for melanocortin-1 but not melanocortin 2-5. The number of receptors and receptor mRNA was upregulated by endoxin or mitogens.
29. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88:131-141.
30. Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthese with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996; 97:2377-2383.
31. Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, Star RA. α-MSH inhibits •• renal injury in the absence of neutrophils. Kidney Int 1998 (in press). α-MSH was effective in ischemia/reperfusion models where neutrophils were less prominent or absent.
32. ••], was performed to investigate whether α-MSH could protect against renal injury independently of its actions on neutrophils. Kidneys were perfused ex vivo without neutrophils, subjected to ex vivo ischemia, then reperfused ex vivo without neutrophils. α-MSH protected glomerular and tubular function, suggesting that it has direct effects on the kidney independent of neutrophil-mediated tissue injury.